Financials
- Market Capitalization 217.78 M
- Employee 34
- Founded 2004
- CEO Christopher U. Missling Ph.D.
- Website www.anavex.com
- Headquarter New York, United States
- FIGI BBG000C9K8K4
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-16.48
Fiyat/satışlar oranı
151.51
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3577 | KROS Keros Therapeutics, Inc. - common stock | 10.88 USD | -1.98% | -2.77% | +5.12% | -27.95% | 215.34 M USD | ||
| 3580 | BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.33 USD | -0.46% | -1.59% | +2.36% | -46.74% | 218.12 M USD | ||
| 3584 | CGEN Compugen Ltd. - Ordinary Shares | 2.26 USD | -1.74% | -3.83% | +11.33% | +40.37% | 213.69 M USD | ||
| 3589 | NBP NovaBridge Biosciences - American Depositary Shares | 1.83 USD | -1.61% | -9.41% | +23.65% | -59.42% | 211.15 M USD |